|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
|
CO5270018A1
(es)
*
|
1999-12-11 |
2003-04-30 |
Glaxo Group Ltd |
Distribuidor de medicamento
|
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
|
ME00220B
(me)
|
2000-05-22 |
2010-10-10 |
Chiesi Farm Spa |
Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
|
|
US20060257324A1
(en)
*
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
|
FR2812545B1
(fr)
*
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
|
US20040081627A1
(en)
*
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
|
WO2002030928A1
(de)
*
|
2000-10-12 |
2002-04-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
|
|
US20020137764A1
(en)
|
2000-10-31 |
2002-09-26 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
|
EA009068B1
(ru)
*
|
2000-10-31 |
2007-10-26 |
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг |
Ингаляционная композиция в виде раствора с солью тиотропия
|
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
|
HU229798B1
(en)
*
|
2001-03-30 |
2014-07-28 |
Jagotec Ag |
Medical aerosol compositions and process for their preparation
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
|
US6472563B1
(en)
*
|
2001-11-09 |
2002-10-29 |
Sepracor Inc. |
Formoterol tartrate process and polymorph
|
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
|
PT3536344T
(pt)
*
|
2002-03-01 |
2020-03-26 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
|
US7244415B2
(en)
*
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
|
US7311894B2
(en)
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
|
DE10214264A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
|
DE10214263A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
|
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
|
GB0207899D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and cielesonide aerosol formulations
|
|
JP5160018B2
(ja)
*
|
2002-06-25 |
2013-03-13 |
アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド |
非晶質医薬組成物を用いる経皮送達速度調節
|
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
|
DK1572622T3
(da)
*
|
2002-12-10 |
2006-08-28 |
Sepracor Inc |
Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator
|
|
JP4755495B2
(ja)
*
|
2002-12-12 |
2011-08-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
組合せ医薬品
|
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
|
CN1292748C
(zh)
*
|
2003-03-05 |
2007-01-03 |
南昌弘益科技有限公司 |
噻托溴铵吸入粉雾剂及其制备工艺
|
|
ME00420B
(me)
*
|
2003-03-20 |
2011-12-20 |
Boehringer Ingelheim Pharmaceuticals Inc |
Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
|
|
AU2004241746A1
(en)
*
|
2003-05-22 |
2004-12-02 |
Nycomed Gmbh |
Salmeterol and ciclesonide combination
|
|
GB0312148D0
(en)
*
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
|
EP1635845A1
(en)
|
2003-06-13 |
2006-03-22 |
ALTANA Pharma AG |
Formoterol and ciclesonide combination
|
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
WO2005013963A1
(en)
*
|
2003-08-06 |
2005-02-17 |
Galephar M/F |
Advantageous combinations for inhalation of nacystelyn and bronchodilators
|
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
|
WO2005025578A1
(en)
*
|
2003-09-16 |
2005-03-24 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases
|
|
US20070189979A1
(en)
*
|
2003-09-18 |
2007-08-16 |
Norton Healthcare Limited T/A Ivax Pharmaceuticals |
Particles
|
|
GB0323685D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
GB0323684D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
PT1713471E
(pt)
*
|
2004-02-06 |
2012-04-10 |
Meda Pharma Gmbh & Co Kg |
Combinação de anticolinérgicos e inibidores de fosfodiesterase tipo 4 para o tratamento de doenças respiratórias
|
|
PL1718336T3
(pl)
*
|
2004-02-06 |
2008-11-28 |
Meda Pharma Gmbh & Co Kg |
Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowego
|
|
EP1713473B1
(en)
|
2004-02-06 |
2013-03-13 |
MEDA Pharma GmbH & Co. KG |
The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
|
|
US20070185067A1
(en)
*
|
2004-02-27 |
2007-08-09 |
Altana Pharma Ag |
Ciclesonide and glycopyrronium combination
|
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
|
WO2005102354A1
(en)
*
|
2004-04-20 |
2005-11-03 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
|
|
US20050238632A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Alburty David S |
Propellant formulations
|
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
|
CA2562585A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Cydex, Inc. |
Dpi formulation containing sulfoalkyl ether cyclodextrin
|
|
ITRM20040268A1
(it)
*
|
2004-05-31 |
2004-08-31 |
Italchimici S P A |
Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
CA2571519C
(en)
*
|
2004-07-02 |
2013-05-14 |
Boehringer Ingelheim International Gmbh |
Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
|
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
|
US8343467B2
(en)
|
2004-12-27 |
2013-01-01 |
Beiersdorf Ag |
Glycopyrrolate in cosmetic preparations
|
|
DE102005029390A1
(de)
*
|
2005-06-23 |
2007-01-04 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen
|
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
|
JP4991693B2
(ja)
*
|
2005-03-16 |
2012-08-01 |
メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
|
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
|
WO2006114379A1
(de)
*
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
|
|
JP5227790B2
(ja)
|
2005-05-02 |
2013-07-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規結晶性臭化チオトロピウム
|
|
CN102091079B
(zh)
*
|
2005-06-03 |
2014-03-12 |
艾克若克斯Dds有限公司 |
用于透皮给药的方法和组合物
|
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
|
AU2006329042B2
(en)
|
2005-12-21 |
2012-02-02 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
DE102006017320A1
(de)
*
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
|
ES2298049B1
(es)
*
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
|
CN101568339A
(zh)
*
|
2006-12-07 |
2009-10-28 |
伊莱利利公司 |
普拉格雷的制品
|
|
DE102007002121B4
(de)
*
|
2007-01-10 |
2008-12-11 |
Dräger, Karl-Heinz |
Verwendung eines Flüssiggasgemisches als nichtbrennbares Treibgas zum Feinstverteilen eines Reiz- oder Kampfstoffes
|
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
WO2010138862A2
(en)
*
|
2009-05-29 |
2010-12-02 |
Pearl Therapeutics, Inc. |
Compositions for respiratory delivery of active agents and associated methods and systems
|
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
|
TR200907237A2
(tr)
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum kuru toz kombinasyonu
|
|
GB0918149D0
(en)
*
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
|
TR200907914A2
(tr)
*
|
2009-10-20 |
2011-05-23 |
Bi̇lgi̇ç Mahmut |
Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
|
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
|
MY156950A
(en)
|
2009-12-23 |
2016-04-15 |
Chiesi Farma Spa |
Aerosol formulation for copd
|
|
KR101757951B1
(ko)
*
|
2009-12-23 |
2017-07-13 |
키에시 파르마슈티시 엣스. 피. 에이. |
Ｃｏｐｄ용 조합요법
|
|
WO2011076841A2
(en)
*
|
2009-12-23 |
2011-06-30 |
Chiesi Farmaceutici S.P.A. |
Combination therapy for copd
|
|
TR200909790A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
|
TR200909793A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
|
TR200909789A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
|
TR200909791A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
|
TR200909792A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
|
WO2012171903A1
(en)
|
2011-06-15 |
2012-12-20 |
Nycomed Gmbh |
Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
|
|
AR086915A1
(es)
|
2011-06-17 |
2014-01-29 |
Nycomed Gmbh |
Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
|
WO2014099673A1
(en)
|
2012-12-17 |
2014-06-26 |
Parion Sciences, Inc. |
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
|
US9593084B2
(en)
|
2012-12-17 |
2017-03-14 |
Parion Sciences, Inc. |
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
|
|
WO2014113638A1
(en)
*
|
2013-01-17 |
2014-07-24 |
Aer Devices, Inc. |
Multi-use albuterol maintenance therapy formulations and devices therefor
|
|
MX361286B
(es)
|
2013-03-15 |
2018-12-03 |
Pearl Therapeutics Inc |
Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
|
|
GB201306984D0
(en)
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
|
EP3384898A1
(en)
|
2013-12-30 |
2018-10-10 |
Chiesi Farmaceutici S.p.A. |
Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
|
|
EP3725311A1
(en)
*
|
2014-02-10 |
2020-10-21 |
Respivant Sciences GmbH |
Methods for the treatment of lung diseases with mast cell stabilizers
|
|
US20150224077A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders
|
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
CN112472689B
(zh)
|
2015-12-04 |
2023-01-17 |
墨西哥氟石股份公司 |
药物组合物
|
|
CA3035528A1
(en)
|
2016-08-31 |
2018-03-08 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
|
WO2018051133A1
(en)
|
2016-09-19 |
2018-03-22 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
|
ES2949975T3
(es)
|
2016-09-19 |
2023-10-04 |
Mexichem Fluor Sa De Cv |
Composición farmacéutica que comprende indacaterol
|
|
CA3037092C
(en)
|
2016-09-19 |
2022-06-21 |
Mexichem Fluor S.A. De C.V. |
Stable pharmaceutical compositions comprising glycopyrrolate and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
|
|
JP2019531308A
(ja)
|
2016-10-07 |
2019-10-31 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
肺線維症の治療のためのクロモリン組成物
|
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
|
EP3525773A1
(en)
*
|
2016-10-14 |
2019-08-21 |
Glenmark Specialty S.A. |
Nebulizable compositions of tiotropium and formoterol
|
|
UA122811C2
(uk)
*
|
2018-08-10 |
2021-01-06 |
Наталія Миколаївна Тихонівська |
Фармацевтична композиція
|
|
PE20221439A1
(es)
|
2019-12-02 |
2022-09-21 |
Chiesi Farm Spa |
Lata de acero inoxidable para inhaladores dosificadores presurizados
|
|
CN112972384B
(zh)
*
|
2019-12-02 |
2022-03-18 |
长风药业股份有限公司 |
一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
|
|
WO2023227781A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
|
WO2023227783A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
|
WO2023227782A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|